Company Overview - Tempus AI, Inc. is a health technology company focused on developing AI-driven diagnostic tools for healthcare providers and researchers [3] Allegations and Impact - On May 28, 2025, Spruce Point Capital Management published a report raising concerns about Tempus AI's financial reporting methods and the involvement of its board members and executives with companies that had previously restated their financial results [4] - Following the report, Tempus AI's stock price fell by $12.67 per share, representing a decline of 19.23%, closing at $53.20 per share on the same day [4] Legal Investigation - Edelson Lechtzin LLP is investigating potential violations of federal securities laws related to Tempus AI, stemming from allegations of misleading business information provided to the investing public [1]
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of Tempus AI Inc. (NASDAQ: TEM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm